Pure Global

Predicting Toxicity in Elderly Patients With Head and Neck Cancer - Trial NCT06344208

Access comprehensive clinical trial information for NCT06344208 through Pure Global AI's free database. This phase not specified trial is sponsored by European Institute of Oncology and is currently Recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 3 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06344208
Recruiting
Trial Details
ClinicalTrials.gov • NCT06344208
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Predicting Toxicity in Elderly Patients With Head and Neck Cancer
Predicting Toxicity in Elderly Patients With Head and Neck Cancer: Validating a Disease-oriented Toxicity Predictive Tool and Integrating it With Available Screening Tools for Better Outcomes

Study Focus

Head and Neck Cancer

Observational

Sponsor & Location

European Institute of Oncology

Milan, Italy

Timeline & Enrollment

N/A

Mar 15, 2022

Dec 31, 2024

3 participants

Primary Outcome

Predicting toxicity in elderly patients with head and neck cancer

Summary

Predicting toxicity in elderly patients with head and neck cancer:
 
 validating a disease-oriented toxicity predictive tool and integrating it with avail-able
 screening tools for better outcomes.

ICD-10 Classifications

Malignant neoplasm of other and ill-defined sites: Head, face and neck
Malignant neoplasm: Skin of scalp and neck
Malignant neoplasm: Connective and soft tissue of head, face and neck
Carcinoma in situ: Skin of scalp and neck
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

Data Source

ClinicalTrials.gov

NCT06344208

Non-Device Trial